The management of nutritional rickets primarily involves the administration of Vitamin D and calcium. Historically, high-dose “Stoss” therapy was popular, but current guidelines favor daily low-dose regimens due to safety concerns.
1. Daily Low-Dose Vitamin D Therapy (Current Standard of Care)
This approach involves the administration of physiological or slightly pharmacological doses of Vitamin D over a prolonged period to gradually replenish body stores.
Regimen Details
- Dosage: The recommended dosage varies by age:
- Infants (< 1 year): 2000 IU/day,.
- Children (> 1 year): 3000–6000 IU/day,,.
- Duration: Therapy is typically continued for 12 weeks (3 months) to ensure complete healing of osteomalacia and replenishment of stores,.
- Maintenance: Following the 12-week intensive phase, the child is transitioned to a daily maintenance dose of 400 IU (infants) to 600 IU (children) to prevent recurrence,.
- Adjuncts: Oral calcium supplementation (30–75 mg/kg/day) is mandatory during the initial phase to prevent hypocalcemia caused by rapid bone remineralization (“hungry bone syndrome”),,.
Advantages
- Safety Profile: This method is significantly safer than high-dose therapy. It minimizes the large spikes in serum Vitamin D levels that can lead to toxicity.
- Reduced Renal Risk: There is a much lower risk of developing hypercalciuria (excess calcium in urine) and nephrocalcinosis (calcium deposition in kidneys) compared to Stoss therapy.
- Physiological Repletion: It allows for a more controlled and steady restoration of bone mineralization and Vitamin D status.
- Efficacy: Current guidelines state that this method is not only safer but also a more effective way to treat rickets compared to single massive doses.
Disadvantages
- Compliance: The primary drawback is the need for strict adherence to daily medication for a long duration (12 weeks).
- Reliability: In settings with poor social support or understanding, parents may forget doses, leading to treatment failure.
2. Stoss Therapy (Mega-Dose Therapy)
“Stoss” is derived from a German word meaning “push.” This therapy involves administering a massive dose of Vitamin D to rapidly fill body stores.
Regimen Details
- Dosage: A massive dose of 300,000 to 600,000 IU of Vitamin D is administered,,.
- Administration:
- It can be given as a single oral or intramuscular dose,.
- Alternatively, it can be divided into 2–4 doses given over a 24-hour period.
- If radiological healing is not observed within 2–3 weeks, the dose may sometimes be repeated.
- Mechanism: Vitamin D is fat-soluble and is stored in the adipose tissue and muscle, from where it is slowly released over months.
Advantages
- Guaranteed Compliance: Because the entire course is administered under medical supervision (often as a single observed dose), compliance is ensured.
- Convenience: It avoids the need for daily administration by parents, making it useful in populations where long-term adherence is questionable or follow-up is difficult,.
- Rapid Stores: It rapidly fills the body’s Vitamin D pool.
Disadvantages
- Hypercalcemia: The massive influx of Vitamin D can lead to dangerously high serum calcium levels (hypercalcemia),.
- Hypercalciuria and Nephrocalcinosis: High calcium excretion in the urine is a frequent complication, which significantly increases the risk of renal stones and nephrocalcinosis (permanent calcium deposits in the kidney tissue),,.
- Toxicity: There is a narrow therapeutic index with such high doses, increasing the risk of Vitamin D toxicity (Hypervitaminosis D).
- Monitoring Requirements: Due to toxicity risks, closer monitoring of serum calcium and urinary calcium is ideally required, which may not always be feasible in resource-limited settings.
3. Intermediate/Alternative Strategies
To balance the safety of daily dosing with the convenience of Stoss therapy, alternative intermittent regimens have been proposed.
- Weekly/Fortnightly Dosing: In older children where daily compliance is doubtful, higher doses (e.g., 60,000 IU) can be given once weekly or once every two weeks for a total of roughly 300,000–600,000 IU over a few weeks,.
- Therapeutic Trial: A specific trial of Stoss therapy (600,000 IU) is sometimes used diagnostically to differentiate nutritional rickets from refractory rickets (X-linked hypophosphatemia or Vitamin D dependent rickets). If no healing occurs after 4-6 weeks of this massive dose, the rickets is termed “refractory”,.
Summary of Differences
| Feature | Daily Low-Dose Therapy | Stoss Therapy |
|---|---|---|
| Dose | 2000–6000 IU/day | 300,000–600,000 IU (Stat/24hr) |
| Duration | 12 weeks | 1 day (Single/Split dose) |
| Safety | High | Lower (Risk of toxicity) |
| Risk of Nephrocalcinosis | Minimal | Significant |
| Compliance | Dependent on caregiver (variable) | 100% (Observed) |
| Current Recommendation | Preferred/Standard of Care | Reserved for non-compliant cases |